Group Action Lawyers
Latest News & Updates

iphone
May 16, 2018
Apple allegedly concealed iPhone battery issues

Apple allegedly concealed iPhone battery issues, according to court papers filed in a group action lawsuit against the tech-giant.

It’s alleged that Apple failed – or neglected – to inform owners that there was a fault with the iPhone 6 model battery, and that it could be resolved with a new battery as opposed to a new handset.

With the likes of Samsung being sued for exploding batteries, and Apple having already admitted that older handsets slowdown with software updates, this latest battery scandal is one in a long line of issues people seem to be having with today’s modern mobile technology.

Continue Reading…

medical device recall
May 11, 2018
Group Action Lawyers contacted for help after NHS Breast Cancer Screening Scandal

The Group Action Lawyers have been contacted for help after the news broke about the NHS Breast Cancer Screening Scandal. Individuals who did not receive their invitation for breast cancer screening and have since developed breast cancer, or families of patients who have passed away because the patient was not offered screening, may be entitled to take legal action.

A computer glitch has been blamed for the error that resulted in some 450,000 women aged between 68 and 71 reportedly not receiving their invitation for breast cancer screening because a computer program is said to have had the cut-off age at 70 by mistake. What’s worse is that it has taken nine years for the problem to be identified, with the glitch occurring sometime in 2009.

Continue Reading…

talcum powder ovarian cancer link
May 09, 2018
J & J reportedly loses mistrial bid in asbestos talcum powder case

J & J has reportedly lost a mistrial bid in an asbestos talcum powder trial in America. The legal team representing Johnson & Johnson – a pharmaceutical and medical manufacturing giant – reportedly took issue with comments made by the lawyers fighting for compensation for a male claiming damages for asbestos-related illness that he alleges was caused by the use of J & J talcum powder.

Talcum powder has been linked with the dangerous cancer mesothelioma, which can be caused by exposure to asbestos, and a number of legal claims have seen some success in finding J & J liable for allowing their talcum powder products to contain the dangerous substance that is mined closely to where talc is produced.

Continue Reading…

pelvic mesh inquiry vaginal mesh implants concerns
May 04, 2018
Pelvic mesh devices “rushed to market” without proper testing and warnings

Some pelvic mesh devices were reportedly “rushed to market” without proper testing and warnings for women, the legal team for a Claimant pursuing damages for pelvic mesh injuries claims.

According to the reports, manufacturer C.R. Bard moved pelvic mesh devices to market quickly and failed to properly test the devices and provide sufficient warnings over their use.

The Claimant alleges that the ‘Avaulta Solo Support System’ and the ‘Align Trans-Obturator Urethral Support System’ are unsafe, and inadequate warnings were provided to her. She has reportedly suffered debilitating injuries.
Continue Reading…

cancer screening scandal
May 02, 2018
Group Action Lawyers investigating NHS Breast Cancer Screening Scandal

The Group Action Lawyers are investigating the NHS Breast Cancer Screening Scandal which has broken in the news this week.

Our Group Action Lawyers say there may be legal cases to answer for as Health Secretary, Jeremy Hunt, confirms that 270 women may have died as a direct result of an IT glitch that lead to them NOT receiving vital and potentially life-saving letters inviting them for periodic breast cancer screening.

It’s thought that women aged between 68 and 71 are affected by the glitch that occurred in 2009 that was discovered by Public Health England in January this year.
Continue Reading…

volkswagen class action
May 01, 2018
Will the Volkswagen class action change the way the UK handles Group Litigation?

Will the Volkswagen class action change the way the UK handles Group Litigation Order cases? We have never had a class action of this kind of scale and nature in the UK before, and whilst our American cousins are used to dealing with class actions involving millions of people, the UK, typically, is not.

The UK Volkswagen compensation case could include more than 2 million potential claimants. That is monumental in any scope of class actions here in the UK, and this action may set some important precedents for the future.

In some ways, we hope this may be a catalyst for change.
Continue Reading…

anti-depressants prescriptions for children
April 27, 2018
Xarelto side-effects when mixed with other drugs

The issue of Xarelto side-effects when mixed with other drugs is currently being considered as part of the ongoing court action for negligence claims against the manufacturers of Xarelto who allegedly failed to warn users of dangerous side-effects related to use of the drug.

The blood-thinning, anti-stroke drug Xarelto – also sold under the name Rivaroxaban – has been linked to internal bleeding, and negligence claims against the manufacturers are over whether they knew of the risks of internal bleeding associated with the product but failed to warn anyone.

Our Group Action Lawyers have taken on cases to investigate claims here in the UK.
Continue Reading…

new research into exploding e-cigs
April 25, 2018
“Smoke” from e-cigarettes linked to DNA damage and increased health risks

“Smoke” from e-cigarettes has been linked to DNA damage and increased health risks, scientists have warned.

Tests conducted on mice indicated that exposure to e-cigarette smoke (or rather the vapour that the devices produce) could increase the risk of DNA damage, leading to higher risks of cancer and heart disease.

The hotly-debated tobacco replacement products have soared in popularity off the back of claims that they’re far safer than smoking, but with the industry still in its infancy, there are still a number of unknowns when it comes to their overall safety.
Continue Reading…

skin beauty products useless claim experts
April 23, 2018
Warnings issued over false “hypoallergenic” and “fragrance-free” claims

Warnings have been issued over reportedly false “hypoallergenic” and “fragrance-free” claims for huge volumes of skincare products. According to recent research, the ingredients of the top 100 best-selling moisturisers sold by vendors like Amazon were examined, and the results were surprising.

According to the studies, over 80% contained a potentially allergenic substance, and almost half of the products tested did actually contain some form of fragrance.

Not so “hypoallergenic” and “fragrance-free” after all…
Continue Reading…

April 20, 2018
Johnson & Johnson talcum powder and cancer link investigations to begin in the UK

The latest Johnson & Johnson talcum powder cancer trial in the US has concluded with the victim awarded $40m in damages.

The Claimant alleged that his mesothelioma – an aggressive and incurable cancer – was caused by long-term use of J & J talc. In light of key expert evidence that indicated there can be trace amounts of asbestos contained in talcum powder, he has won his case.

There are currently thousands of similar lawsuits in the US, and our Group Action Lawyers are ready to investigate UK cases also.
Continue Reading…

unsatisfactory safety information
April 18, 2018
Resuscitation system recall issued after risk of damage to lungs found

An error with a resuscitation system has been reported to risk damage to lungs, according to information released by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Manufactured by Intersurgical, the manual resuscitation system – named as the “Bag valve mask” (BVM) – risks damage to lungs due to the potential for excess pressure being delivered by the system.

Given that the defect is with a resuscitation system, this recall is an important one as lives may be at risk as a result of it.
Continue Reading…

drug recall
April 13, 2018
Cancer drug recall confirmed by UK regulators

A cancer drug recall has been initiated due to reports of excessive levels of an active ingredient used in the drug.

Pharmaceutical company AstraZeneca UK has initiated the recall, primarily for batch NG327, because the “level of olaparib polymorphic form L exceeds the registered specification limit”.

As well as the batch being recalled above, there are other batches that are a part of the recall as well, which is all said to be a part of a precautionary measure.
Continue Reading…